Reading HCAT? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track HCAT free→Reading HCAT? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track HCAT free→QuarterlyIQ Insights · HCAT
Price, valuation, and the composite score on the same time axis. Scroll over the price chart to zoom.
Daily closes. Earnings/event dots inline.
A consensus fair price across 4 valuation methods, at three horizons. Current price $1.85. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
No-growth: today's peer multiple on trailing earnings. The headline read.
Embeds projected growth. Leans optimistic by design. Upside context.
Each method's implied share price per horizon. Provisional rows use a projected (historical-CAGR) growth input rather than analyst or management guidance.
| Method | Horizon | Est. price | Multiple | Per-share input | EPS source | Confidence |
|---|---|---|---|---|---|---|
| Peer P/FCF | 12M | $1.59 | 12.5 | 0.13 | TTM | high |
| Peer P/E | 12M | $2.89 | 14.5 | 0.20 | TTM | high |
| Peer P/S | 12M | $7.52 | 1.7 | 4.45 | TTM | high |
| triangulated | 12M | $2.97 | 14.5 | 0.21 | Triangulated | high |
| Peer P/E | 3Y |
Monthly trailing P/E with quartile reference lines.
A “consensus-then vs. actual-now” overlay is on the way — what our valuation estimate said on a past date versus where the price actually landed.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Long-thesis check; widest uncertainty.
| $0.65 |
| 14.5 |
| 0.04 |
| Analyst |
| low |
| Peer P/S | 3Y | $4.87 | 1.7 | 2.88 | Analyst | low |
| Peer P/E | 5Y | $0.24 | 14.5 | 0.02 | Analyst | low |
| Peer P/S | 5Y | $3.65 | 1.7 | 2.16 | Analyst | low |